Metabolomics is a revolutionary new science with immense potential to transform the way we make the modern medical diagnostic decisions and improve our understanding of the world around us. The major challenge of using metabolomics to inform rapid diagnostics is its complexity. Currently, it takes specialized expertise and expensive hardware to perform metabolomic analyses of biological samples, making it difficult and cost-prohibitive to implement in real-world diagnostic laboratories or other high-throughput bio-sampling applications. Because of this, metabolomics-based technological platforms have yet to gain a significant share of the emerging global market for rapid diagnostic tools. This growing market is currently valued at ~$10B (for blood stream infection diagnostics alone) and represents a significant opportunity to establish novel, revolutionary innovations that will capitalize on the future growth anticipated within this sector.